相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Discovery of Benzocyclic Sulfone Derivatives as Potent CXCR2 Antagonists for Cancer Immunotherapy
Yi Dong et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Design and Characterization of an Intracellular Covalent Ligand for CC Chemokine Receptor 2
Natalia V. Ortiz Zacarias et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Discovery of 1,5-Dihydro-4H-imidazol-4-one Derivatives as Potent, Selective Antagonists of CXC Chemokine Receptor 2
Jinxin Che et al.
ACS MEDICINAL CHEMISTRY LETTERS (2021)
Anticancer opportunities at every stage of chemokine function
Natalia V. Ortiz Zacarias et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2021)
The Inside Story: Crystal Structure of the Chemokine Receptor CCR7 with an Intracellular Allosteric Antagonist
Shirsha Saha et al.
BIOCHEMISTRY (2020)
Revealing the Positive Binding Cooperativity Mechanism between the Orthosteric and the Allosteric Antagonists of CCR2 by Metadynamics and Gaussian Accelerated Molecular Dynamics Simulations
Xiaoli An et al.
ACS CHEMICAL NEUROSCIENCE (2020)
Understanding the mechanisms that facilitate specificity, not redundancy, of chemokine-mediated leukocyte recruitment
Douglas P. Dyer
IMMUNOLOGY (2020)
Structural basis of CXC chemokine receptor 2 activation and signalling
Kaiwen Liu et al.
NATURE (2020)
CXCR2 antagonist for patients with chronic obstructive pulmonary disease with chronic mucus hypersecretion: a phase 2b trial
Aili L. Lazaar et al.
RESPIRATORY RESEARCH (2020)
Chemokines in COPD: From Implication to Therapeutic Use
Pauline Henrot et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Chemokine Receptor Crystal Structures: What Can Be Learned from Them?
Marta Arimont et al.
MOLECULAR PHARMACOLOGY (2019)
Structural Basis for Allosteric Ligand Recognition in the Human CC Chemokine Receptor 7
Kathrin Jaeger et al.
CELL (2019)
Synthesis and Pharmacological Evaluation of Triazolopyrimidinone Derivatives as Noncompetitive, Intracellular Antagonists for CC Chemokine Receptors 2 and 5
Natalia V. Ortiz Zacarias et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Discovery of Novel 1-Cyclopentenyl-3-phenylureas as Selective, Brain Penetrant, and Orally Bioavailable CXCR2 Antagonists
Hongfu Lu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Emerging Paradigm of Intracellular Targeting of G Protein-Coupled Receptors
Madhu Chaturvedi et al.
TRENDS IN BIOCHEMICAL SCIENCES (2018)
Intracellular Receptor Modulation: Novel Approach to Target GPCRs
Natalia V. Ortiz Zacarias et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
Ligand-based pharmacophore model for the discovery of novel CXCR2 antagonists as anti-cancer metastatic agents
Jinxin Che et al.
ROYAL SOCIETY OPEN SCIENCE (2018)
Pyrrolone Derivatives as Intracellular Allosteric Modulators for Chemokine Receptors: Selective and Dual-Targeting Inhibitors of CC Chemokine Receptors 1 and 2
Natalia V. Ortiz Zacarias et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Structural Analysis of Chemokine Receptor-Ligand Interactions
Marta Arimont et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Danirixin: A Reversible and Selective Antagonist of the CXC Chemokine Receptor 2
Jakob Busch-Petersen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
Applying Structure-Based Drug Design Approaches to Allosteric Modulators of GPCRs
Miles Congreve et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
AZD8797 is an allosteric non-competitive modulator of the human CX3CR1 receptor
Linda Cederblad et al.
BIOCHEMICAL JOURNAL (2016)
CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma
Colin W. Steele et al.
CANCER CELL (2016)
Chemokine and cytokine levels in inflammatory bowel disease patients
Udai P. Singh et al.
CYTOKINE (2016)
PHARMACOLOGY Inside-out receptor inhibition
Thomas P. Sakmar et al.
NATURE (2016)
Structure of CC chemokine receptor 2 with orthosteric and allosteric antagonists
Yi Zheng et al.
NATURE (2016)
Intracellular allosteric antagonism of the CCR9 receptor
Christine Oswald et al.
NATURE (2016)
Discovery of CNS Penetrant CXCR2 Antagonists for the Potential Treatment of CNS Demyelinating Disorders
Heng Xu et al.
ACS MEDICINAL CHEMISTRY LETTERS (2016)
Allosteric Modulation of Chemoattractant Receptors
Marcello Allegretti et al.
FRONTIERS IN IMMUNOLOGY (2016)
Biarylsulfonamide CCR9 inhibitors for inflammatory bowel disease
Jing Zhang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Boronic acid-containing CXCR1/2 antagonists: Optimization of metabolic stability, in vivo evaluation, and a proposed receptor binding model
Dean Y. Maeda et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Boronic acid-containing aminopyridine- and aminopyrimidinecarboxamide CXCR1/2 antagonists: Optimization of aqueous solubility and oral bioavailability
Aaron D. Schuler et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Discovery and evaluation of a novel monocyclic series of CXCR2 antagonists
Rupert P. Austin et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Novel Allosteric Modulators of G Protein-coupled Receptors
Patrick R. Gentry et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
The pharmacokinetics and pharmacodynamics of danirixin (GSK1325756) - a selective CXCR2 antagonist - in healthy adult subjects
Bruce E. Miller et al.
BMC PHARMACOLOGY & TOXICOLOGY (2015)
CXCL1 Triggers Caspase-3 Dependent Tau Cleavage in Long-Term Neuronal Cultures and in the Hippocampus of Aged Mice: Implications in Alzheimer's Disease
Xiao-Fang Zhang et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Pharmacological Characterization of AZD5069, a Slowly Reversible CXC Chemokine Receptor 2 Antagonist
David J. Nicholls et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
The discovery of potent, orally bioavailable pyrazolo and triazolopyrimidine CXCR2 receptor antagonists
David W. Porter et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
The discovery of potent, orally bioavailable pyrimidine-5-carbonitrile-6-alkyl CXCR2 receptor, antagonists
David W. Porter et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
2-Aminopyrimidin-4(1H)-one as the novel bioisostere of urea: Discovery of novel and potent CXCR2 antagonists
Hongfu Lu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Discovery of 2-[5-(4-Fluorophenylcarbamoyl)pyridin-2-yisulfanylmethyl]phenylboronic Acid (SX-517): Noncompetitive Boronic Acid Antagonist of CXCR1 and CXCR2
Dean Y. Maeda et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders
P. Jeffrey Conn et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Discovery and Mapping of an Intracellular Antagonist Binding Site at the Chemokine Receptor CCR2
Annelien J. M. Zweemer et al.
MOLECULAR PHARMACOLOGY (2014)
Synthesis and Structure-Activity Relationships of Indazole Arylsulfonamides as Allosteric CC-Chemokine Receptor 4 (CCR4) Antagonists
Panayiotis A. Procopiou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Substituted 7-Amino-5-thio-thiazolo[4,5-d]pyrimidines as Potent and Selective Antagonists of the Fractalkine Receptor (CX(3)CR1)
Sofia Karlstrom et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
A Randomized Controlled Trial of the Efficacy and Safety of CCX282-B, an Orally-Administered Blocker of Chemokine Receptor CCR9, for Patients with Crohn's Disease
Satish Keshav et al.
PLOS ONE (2013)
Safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2239633, a CC-chemokine receptor 4 antagonist, in healthy male subjects: results from an open-label and from a randomised study
Anthony Cahn et al.
BMC PHARMACOLOGY & TOXICOLOGY (2013)
Antagonism of human CC-chemokine receptor 4 can be achieved through three distinct binding sites on the receptor
Robert J. Slack et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2013)
Multiple Binding Sites for Small-Molecule Antagonists at the CC Chemokine Receptor 2
Annelien J. M. Zweemer et al.
MOLECULAR PHARMACOLOGY (2013)
Lead optimisation of the N1 substituent of a novel series of indazole arylsulfonamides as CCR4 antagonists and identification of a candidate for clinical investigation
Panayiotis A. Procopiou et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
The yin and yang of chemokine receptor activation
Graeme O'Boyle
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Pharmacological modulation of chemokine receptor function
D. J. Scholten et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
G protein-coupled receptors as therapeutic targets for multiple sclerosis
Changsheng Du et al.
CELL RESEARCH (2012)
CCR2 receptor antagonists: Optimization of biaryl sulfonamides to increase activity in whole blood
Gren Z. Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
SB-656933, a novel CXCR2 selective antagonist, inhibits ex vivo neutrophil activation and ozone-induced airway inflammation in humans
Aili L. Lazaar et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Chemokines in health and disease
Dayanidhi Raman et al.
EXPERIMENTAL CELL RESEARCH (2011)
Overcoming hurdles in developing successful drugs targeting chemokine receptors
Thomas J. Schall et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Identification of a sulfonamide series of CCR2 antagonists
Simon Peace et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
A common intracellular allosteric binding site for antagonists of the CXCR2 receptor
K. Salchow et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Nicotinamide Glycolates Antagonize CXCR2 Activity through an Intracellular Mechanism
Dean Y. Maeda et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Characterization of CCX282-B, an Orally Bioavailable Antagonist of the CCR9 Chemokine Receptor, for Treatment of Inflammatory Bowel Disease
Matthew J. Walters et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
3,4-Diamino-1,2,5-thiadiazoleas potent and selective CXCR2 antagonists
Purakkattle Biju et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Fluoroalkyl α side chain containing 3,4-diamino-cyclobutenediones as potent and orally bioavailable CXCR2-CXCR1 dual antagonists
Purakkattle Biju et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Design, synthesis, and evaluation of novel 3-amino-4-hydrazine-cyclobut-3-ene-1,2-diones as potent and selective CXCR2 chemokine receptor antagonists
Shilan Liu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Diaminocyclobutenediones as potent and orally bioavailable CXCR2 receptor antagonists: SAR in the phenolic amide region
Cynthia Aki et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
SB265610 is an allosteric, inverse agonist at the human CXCR2 receptor
M. E. Bradley et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
392 PROTECT-1 Study Demonstrated Efficacy of the Intestine-Specific Chemokine Receptor Antagonist CCX282-B (Traficet-EN) in Treatment of Patients with Moderate to Severe Crohn's Disease
Satish Keshav et al.
GASTROENTEROLOGY (2009)
Nonpeptidergic Allosteric Antagonists Differentially Bind to the CXCR2 Chemokine Receptor
Petra de Kruijf et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Evaluation of a series of bicyclic CXCR2 antagonists
Iain Walters et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Synthesis and structure-activity relationships of new disubstituted phenyl-containing 3,4-diamino-3-cyclobutene-1,2-diones as CXCR2 receptor antagonists
Gaifa Lai et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Synthesis and structure-activity relationships of heteroaryl substituted-3,4-diamino-3-cyclobut-3-ene-1,2-dione CXCR2/CXCR1 receptor antagonists
Younong Yu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
3,4-diamino-2,5-thiadiazole-1-oxides as potent CXCR2/CXCR1 antagonists
Purakkattle Biju et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Discovery of potent, orally bioavailable small-molecule inhibitors of the human CCR2 receptor
Julien Doyon et al.
CHEMMEDCHEM (2008)
Pharmacological profile of JNJ-27141491 [(S)-3-[3,4-difluorophenyl)-propyl]-5-isoxazol-5-yl-2-thioxo-2,3-dihydro-1H-imidazole4-carboxyl acid methyl ester], as a noncompetitive and orally active antagonist of the human chemokine receptor CCR2
Mieke Buntinx et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Identification of a Putative Intracellular Allosteric Antagonist Binding-Site in the CXC Chemokine Receptors 1 and 2
David J. Nicholls et al.
MOLECULAR PHARMACOLOGY (2008)
An intracellular allosteric site for a specific class of antagonists of the CC chemokine G protein-coupled receptors CCR4 and CCR5
Glen Andrews et al.
MOLECULAR PHARMACOLOGY (2008)
Pharmacological characterization of sch527123, a potent allosteric CXCR1/CXCR2 antagonist
Waldemar Gonsiorek et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
3-Arylamino-2H-1,2,4-benzothiadiazin-5-oI 1,1-dioxides as novel and selective CXCR2 antagonists
Yonghui Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
C(4)-alkyl substituted furanyl cyclobutenediones as potent, orally bioavailable CXCR2 and CXCR1 receptor antagonists
Jianhua Chao et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Novel, acidic CCR2 receptor antagonists: Lead optimization
O. A. Dasse et al.
LETTERS IN DRUG DESIGN & DISCOVERY (2007)
SAR studies on thiazolo[4,5-d]pyrimidine based CXCR2 antagonists involving a novel tandem displacement reaction
Fraser Hunt et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Novel, acidic CCR2 receptor antagonists: From hit to lead
D. Zou et al.
LETTERS IN DRUG DESIGN & DISCOVERY (2007)
Comparison of N,N′-diaryisquaramides and N,N′-diarylureas as antagonists of the CXCR2 chemokine receptor
Brent W. McCleland et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Discovery of 2-hydroxy-N,N-dimethyl-3-{2-[[(R)-1-(5-methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobut-1-enylamino}benzamide (SCH 527123):: A potent, orally bioavailable CXCR2/CXCR1 receptor antagonist
Michael P. Dwyer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
N,N′-Diarylcyanoguanidines as antagonists of the CXCR2 and CXCR1 chemokine receptors
Hong Nie et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Synthesis and structure-activity relationships of 3,4-diaminocyclobut-3-ene-1,2-dione CXCR2 antagonists
J. Robert Merritt et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
The chemokine and chemokine receptor superfamilies and their molecular evolution
Albert Zlotnik et al.
GENOME BIOLOGY (2006)
2-mercaptoimidazoles, a new class of potent CCR2 antagonists
G Van Lommen et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Evaluation of potent and selective small-molecule antagonists for the CXCR2 chemokine receptor
KL Widdowson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Discovery of potent and orally bioavailable N,N′-diarylurea antagonists for the CXCR2 chemokine receptor
Q Jin et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Hit-to-lead studies: The discovery of potent, orally bioavailable triazolethiol CXCR2 receptor antagonists
A Baxter et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Chemokine blockade and chronic inflammatory disease: proof of concept in patients with rheumatoid arthritis
JJ Haringman et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
A potent and selective nonpeptide antagonist of CXCR2 inhibits acute and chronic models of arthritis in the rabbit
PL Podolin et al.
JOURNAL OF IMMUNOLOGY (2002)
Nicotinanilides as inhibitors of neutrophil chemotaxis
NS Cutshall et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2002)
Nicotinamide N-oxides as CXCR2 antagonists
NS Cutshall et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
分享论文
